KINGWOOD, Texas— Vision Source’s founder, Glenn D. Ellisor, OD, will transition from chairman and chief executive officer to the newly created position of executive chairman of the corporation effective immediately. Jim Greenwood will assume the role of president and chief executive officer. Greenwood originally joined the company in January as president and chief operating officer.
||Glenn D. Ellisor, OD
Ellisor will continue to lead the company’s board of directors and will remain actively involved in the company’s strategy development, including being the full-time clinical lead of the company and setting the strategic direction of the optometric alliance. Working closely with Ellisor, Greenwood will lead the senior team and will be responsible for the execution of major strategic plans, investments and initiatives.
“With the implementation of the Affordable Care Act, the formation of ACOs, physician consolidation, reimbursement pressures and new technologies, it is clear that the industry is facing more, complex change than ever before,” said Ellisor. “My full-time focus will now be how we best serve independent ODs and our members in this rapidly evolving new environment. This is the appropriate time to transition the chief executive responsibilities to Jim.”
Greenwood brings more than 20 years of health care experience and a proven track record of accomplishment at Concentra, a $1 billion physician practice management company, where Greenwood worked in close partnership with clinical leaders during a time of rapid transformational change. Greenwood also serves on the board of directors for several health care organizations and a health care administration program’s advisory council.
Since founding Vision Source in 1991, Ellisor has served as its top executive in various roles including president, chief executive officer and chairman of the board. Since June 1991, he has owned and co-owned several Vision Source practices and currently owns a multi-doctor practice here.
WellPoint Names Advisory Board
INDIANAPOLIS, Ind.— WellPoint, Inc. (NYSE:WLP) has announced the names
of the members of its new WellPoint Vision Advisory Board created to
help facilitate dialogue with its network of providers. In addition, on
July 25, 2013, the managed care company launched a program to include
1-800 CONTACTS as an in-network provider of contact lenses on its vision
plans. These initiatives are intended to enhance WellPoint’s vision
care offerings by “improving the provider/patient relationship,” Spahr
The WellPoint Advisory Board members are:
- Harry Boparai, OD, medical director at New York Vision
Group, chief of eyecare at Wyckoff Heights Medical Center and Buena Vida
Continuing Care and Rehabilitation Center
- Heath Gilbert, OD, past president of the Ohio Optometric Association and private practice at Dayton Optometric Center
- Douglas Kiefer, OD, LensCrafters in Colorado
- Karin E. Meng, MS, OD, chair, Healthcare Delivery Systems
Committee for the California Optometric Association and private practice
- Steven Richlin, OD, optometry clinic chief, Cedars-Sinai Medical Center, Los Angeles, and private practice
- Robert E. Smith, OD, staff optometrist,
- Eye Associates and private practice
James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
CUMBERLAND, R.I.— Neurotech
Pharmaceuticals, a biotechnology company developing sight-saving
therapies for chronic retinal disease, announced that James Mazzo was
appointed the company’s executive chairman. Mazzo, a long time leader in
the ophthalmic industry, is the former CEO of Abbott Medical Optics
(AMO), is an operating partner at Versant Ventures and was recently
named chairman and CEO of AcuFocus, a Versant portfolio company.
| James Mazzo
As executive chairman, Neurotech said, Mazzo will engage with the
Neurotech team to advance the company’s novel technology platform
through the clinical development stage toward market availability.
Neurotech’s patented core technology platform, Encapsulated Cell
Technology (ECT), is a genetically engineered implant that enables the
continuous delivery of protein drugs directly into the vitreous of the
eye. The company has demonstrated that a single living ECT implant can
treat a diseased retina for two years or more, thereby eliminating the
need for monthly injections, the conventional approach to treating
Jim Mazzo’s 35-year career in the health care industry includes
seven years as chairman, president and CEO of Advanced Medical Optics
(AMO), which was sold to Abbott Labs in 2009 for $2.8 billion. He was
previously with Allergan for over 20 years in a variety of expanding
roles, working and living in the U.S., England, Italy and Canada. He led
the spinoff of AMO from Allergan in 2002, expanding the business into a
$1 billion industry-leading, publicly-traded corporation. Most
recently, he has served as senior vice president, Abbott Laboratories
and president, Abbott Medical Products.
Mondottica International Ltd. Names Tulba New Managing Director
NOTTINGHAM, U.K. – Mondottica
International Ltd. has announced the appointment of Steve Tulba as the
group’s new managing director for Mondottica Limited, effective
| Steve Tulba
Reporting to Michael Jardine, Mondottica International’s chairman,
Tulba will assume overall management responsibility for the EMEA region
and the Americas, the company said. Tulba’s new role takes over many of
the responsibilities held by Mondottica’s former CEO, Bernhard Nuesser,
who left the group in May for a position with Essilor SA.
Tulba is an industry veteran, having served in several key positions
with Inspecs over the last decade. He was most recently based in
Florida as president of Inspecs USA. He will be based at Mondottica’s
European headquarters in Nottingham.
Haag-Streit Appoints Rom Business Development Manager
Mason, Ohio—Haag-Streit USA has appointed
Mike Rom to the newly created position of business development manager,
East. Rom will be working with distributors, teaching institutions,
clinics and customers to build relationships and promote Haag-Streit and
Reliance Medical Products. Rom has been with the company for 18 years.
“The business development manager position is especially important as we
continue to evolve and provide the best possible products and services
to our customers,” said Ernest Cavin, president of Haag-Streit USA.
| Mike Rom
Headquartered in Bern, Switzerland, with its U.S. headquarters in
Mason, Ohio, Haag-Streit manufactures optical instruments for
ophthalmologists and optometrists. ■